NCT02224482 Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS) Status COMPLETED Phase NA
NCT02220829 Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy Status COMPLETED Phase PHASE3
NCT02220517 Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy Status COMPLETED Phase NA
NCT02218606 Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT02213107 Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. Status COMPLETED Phase PHASE2
NCT02212197 Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer Status COMPLETED Phase PHASE2
NCT02209584 Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients Status COMPLETED Phase N/A
NCT02203513 A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT02199197 Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT02198859 Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer Status COMPLETED Phase PHASE1
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. Status UNKNOWN Phase N/A
NCT02185170 DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections Status TERMINATED Phase NA
NCT02182622 LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel Status WITHDRAWN Phase PHASE1
NCT02181192 Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma Status UNKNOWN Phase NA